Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 3 | 2024 | 94 | 1.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 165 | 0.830 |
Why?
|
| MicroRNAs | 2 | 2022 | 305 | 0.710 |
Why?
|
| Mouth Neoplasms | 1 | 2022 | 64 | 0.690 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2026 | 64 | 0.230 |
Why?
|
| Coumaric Acids | 2 | 2015 | 9 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2026 | 130 | 0.220 |
Why?
|
| Insulin | 2 | 2017 | 325 | 0.210 |
Why?
|
| Epithelial Cells | 1 | 2026 | 272 | 0.210 |
Why?
|
| Lung | 1 | 2026 | 389 | 0.200 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 63 | 0.190 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2026 | 227 | 0.180 |
Why?
|
| Liver | 2 | 2015 | 497 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 346 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 417 | 0.150 |
Why?
|
| Fructose | 2 | 2015 | 23 | 0.140 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 110 | 0.130 |
Why?
|
| Plasticizers | 1 | 2017 | 4 | 0.130 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2017 | 6 | 0.130 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 144 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 51 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2026 | 1502 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 63 | 0.120 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2015 | 4 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 98 | 0.100 |
Why?
|
| Humans | 4 | 2026 | 29211 | 0.080 |
Why?
|
| Deoxyglucose | 2 | 2017 | 9 | 0.060 |
Why?
|
| Mouth | 1 | 2026 | 37 | 0.060 |
Why?
|
| Aerosols | 1 | 2026 | 47 | 0.060 |
Why?
|
| Stem Cells | 1 | 2026 | 127 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2017 | 310 | 0.050 |
Why?
|
| Cell Line | 1 | 2026 | 705 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 119 | 0.050 |
Why?
|
| Cisplatin | 1 | 2024 | 186 | 0.050 |
Why?
|
| Rats | 2 | 2017 | 1595 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2026 | 692 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 378 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 473 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1524 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 828 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 790 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 1362 | 0.040 |
Why?
|
| Animals | 3 | 2017 | 10806 | 0.030 |
Why?
|
| Glycogen | 1 | 2017 | 23 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 614 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2015 | 1 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2017 | 268 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cholagogues and Choleretics | 1 | 2015 | 3 | 0.030 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 16 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 153 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 203 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1024 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 355 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 381 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 344 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 176 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 645 | 0.020 |
Why?
|
| Male | 2 | 2015 | 14126 | 0.020 |
Why?
|